Electromed EBITDA Margin 2010-2025 | ELMD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Electromed (ELMD) over the last 10 years. The current EBITDA margin for Electromed as of March 31, 2025 is .
| Electromed EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.06B | $0.01B | 16.13% |
| 2024-12-31 | $0.06B | $0.01B | 16.67% |
| 2024-09-30 | $0.06B | $0.01B | 15.52% |
| 2024-06-30 | $0.06B | $0.01B | 12.73% |
| 2024-03-31 | $0.05B | $0.01B | 11.11% |
| 2023-12-31 | $0.05B | $0.01B | 9.62% |
| 2023-09-30 | $0.05B | $0.00B | 8.00% |
| 2023-06-30 | $0.05B | $0.00B | 8.16% |
| 2023-03-31 | $0.05B | $0.00B | 6.52% |
| 2022-12-31 | $0.04B | $0.00B | 6.82% |
| 2022-09-30 | $0.04B | $0.00B | 7.14% |
| 2022-06-30 | $0.04B | $0.00B | 9.76% |
| 2022-03-31 | $0.04B | $0.00B | 10.26% |
| 2021-12-31 | $0.04B | $0.00B | 7.89% |
| 2021-09-30 | $0.04B | $0.00B | 10.81% |
| 2021-06-30 | $0.04B | $0.00B | 11.43% |
| 2021-03-31 | $0.03B | $0.00B | 12.12% |
| 2020-12-31 | $0.03B | $0.01B | 15.15% |
| 2020-09-30 | $0.03B | $0.01B | 15.15% |
| 2020-06-30 | $0.03B | $0.01B | 18.18% |
| 2020-03-31 | $0.04B | $0.01B | 20.00% |
| 2019-12-31 | $0.03B | $0.01B | 21.21% |
| 2019-09-30 | $0.03B | $0.01B | 18.75% |
| 2019-06-30 | $0.03B | $0.00B | 12.90% |
| 2019-03-31 | $0.03B | $0.00B | 10.00% |
| 2018-12-31 | $0.03B | $0.00B | 10.00% |
| 2018-09-30 | $0.03B | $0.00B | 10.34% |
| 2018-06-30 | $0.03B | $0.00B | 10.71% |
| 2018-03-31 | $0.03B | $0.00B | 14.81% |
| 2017-12-31 | $0.03B | $0.00B | 14.81% |
| 2017-09-30 | $0.03B | $0.00B | 15.38% |
| 2017-06-30 | $0.03B | $0.00B | 15.38% |
| 2017-03-31 | $0.03B | $0.00B | 12.00% |
| 2016-12-31 | $0.02B | $0.00B | 12.50% |
| 2016-09-30 | $0.02B | $0.00B | 12.50% |
| 2016-06-30 | $0.02B | $0.00B | 17.39% |
| 2016-03-31 | $0.02B | $0.00B | 18.18% |
| 2015-12-31 | $0.02B | $0.00B | 14.29% |
| 2015-09-30 | $0.02B | $0.00B | 15.00% |
| 2015-06-30 | $0.02B | $0.00B | 15.00% |
| 2015-03-31 | $0.02B | $0.00B | 15.00% |
| 2014-12-31 | $0.02B | $0.00B | 15.79% |
| 2014-09-30 | $0.02B | $0.00B | 11.11% |
| 2014-06-30 | $0.02B | $0.00B | 6.25% |
| 2014-03-31 | $0.02B | 0 | 0.00% |
| 2013-12-31 | $0.01B | $0.00B | -7.14% |
| 2013-09-30 | $0.01B | $0.00B | -7.14% |
| 2013-06-30 | $0.02B | $0.00B | -6.67% |
| 2013-03-31 | $0.02B | $0.00B | -6.25% |
| 2012-12-31 | $0.02B | 0 | 0.00% |
| 2012-09-30 | $0.02B | 0 | 0.00% |
| 2012-06-30 | $0.02B | $0.00B | 5.00% |
| 2012-03-31 | $0.02B | $0.00B | 10.00% |
| 2011-12-31 | $0.02B | $0.00B | 15.00% |
| 2011-09-30 | $0.02B | $0.00B | 20.00% |
| 2011-06-30 | $0.02B | $0.00B | 15.79% |
| 2011-03-31 | $0.02B | $0.00B | 11.11% |
| 2010-12-31 | $0.02B | $0.00B | 11.76% |
| 2010-09-30 | $0.02B | $0.00B | 6.67% |
| 2010-06-30 | $0.01B | $0.00B | 14.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.168B | $0.055B |
| Electromed, Inc. manufactures, markets and sells products that provide airway clearance therapy to patients with compromised pulmonary function. The Company is the designer, manufacturer and worldwide provider of the SmartVest? Airway Clearance System and related products. The patented system uses High Frequency Chest Wall Oscillation (HFCWO), an alternative to Chest Physiotherapy (CPT), to deliver airway clearance treatment. The Company manufactures its products for use by chronically-ill patients who face health risks due to pneumonia and mucus accumulation in the lungs, particularly patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company's products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $188.546B | 82.58 |
| Thermo Fisher Scientific (TMO) | United States | $162.598B | 19.67 |
| Edwards Lifesciences (EW) | United States | $46.224B | 30.31 |
| Alcon (ALC) | Switzerland | $43.751B | 29.57 |
| IDEXX Laboratories (IDXX) | United States | $43.516B | 50.01 |
| DexCom (DXCM) | United States | $33.510B | 51.79 |
| IQVIA Holdings (IQV) | United States | $28.637B | 16.04 |
| Mettler-Toledo (MTD) | United States | $25.693B | 30.56 |
| STERIS (STE) | Ireland | $22.696B | 25.00 |
| Waters (WAT) | United States | $21.023B | 29.66 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.706B | 0.00 |
| Hologic (HOLX) | United States | $14.897B | 16.19 |
| Sysmex ADR (SSMXY) | Japan | $10.505B | 29.80 |
| Penumbra (PEN) | United States | $9.444B | 74.12 |
| Masimo (MASI) | United States | $9.018B | 33.26 |
| Globus Medical (GMED) | United States | $7.825B | 18.65 |
| Glaukos (GKOS) | United States | $6.088B | 0.00 |
| Teleflex (TFX) | United States | $5.300B | 8.75 |
| Integer Holdings (ITGR) | United States | $4.249B | 22.26 |
| TransMedics (TMDX) | United States | $4.221B | 91.75 |
| PROCEPT BioRobotics (PRCT) | United States | $3.276B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.545B | 15.15 |
| Veracyte (VCYT) | United States | $2.155B | 30.24 |
| Nihon Kohden (NHNKY) | Japan | $2.134B | 24.47 |
| Elekta AB (EKTAY) | Sweden | $1.961B | 17.63 |
| Alphatec Holdings (ATEC) | United States | $1.693B | 0.00 |
| Artivion (AORT) | United States | $1.390B | 130.24 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.077B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.023B | 5.44 |
| SiBone (SIBN) | United States | $0.800B | 0.00 |
| IRadimed (IRMD) | United States | $0.756B | 38.37 |
| Semler Scientific (SMLR) | United States | $0.629B | 13.64 |
| Beta Bionics (BBNX) | United States | $0.588B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.567B | 8.82 |
| AxoGen (AXGN) | United States | $0.549B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.545B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.493B | 11.55 |
| Pacific Biosciences Of California (PACB) | United States | $0.450B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.445B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.437B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.391B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.385B | 0.00 |
| RxSight (RXST) | United States | $0.344B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.335B | 0.00 |
| NeuroPace (NPCE) | United States | $0.334B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.267B | 0.00 |
| 908 Devices (MASS) | United States | $0.259B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.239B | 14.45 |
| Neuronetics (STIM) | United States | $0.234B | 0.00 |
| Inogen (INGN) | United States | $0.197B | 0.00 |
| CVRx (CVRX) | United States | $0.181B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.160B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.148B | 0.00 |
| Accuray (ARAY) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.128B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.120B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.096B | 0.00 |
| Spectral AI (MDAI) | United States | $0.078B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.075B | 45.80 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.061B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.22 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.023B | 0.00 | |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.69 |